Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Approved
Publication channel information
Title of journal/series
The Lancet Oncology
ISSN (print)
1470-2045
ISSN (electronic)
1474-5488
ISSN (linking)
1470-2045
Publication forum ID
62403
Publication forum level
3
Country of publication
United Kingdom
Internationality
Yes
Detailed publication information
Publication year
2013
Reporting year
2013
Journal/series volume number
14
Journal/series issue number
9
Page numbers
823-33
DOI
10.1016/S1470-2045(13)70274-2
Language of publication
English
Co-publication information
International co-publication
Yes
Classification and additional information
MinEdu field of science classification
3111 Biomedicine